Health systems are increasingly turning to automation, AI and centralized fulfillment models to address pharmacist shortages, space limitations and rising operational demands. A recent panel discussion at Becker’s 2025 Fall Chief Pharmacy Officer Summit, moderated by Tom Utech, PharmD, iA…
Pharmacy
When pharmacy leaders look 20, 30 or even 50 years ahead, they don’t see a future shaped by a single breakthrough. Instead, they describe a profession undergoing structural transformation — driven by automation, data integration, and an expanding clinical and…
Novartis received breakthrough therapy designation from the FDA for ianalumab, a monoclonal antibody aimed at treating Sjögren’s disease. Ianalumab works by depleting B cells and blocking BAFF-R signaling, which inhibits B-cell activation and survival. The drugmaker, based in Switzerland, plans…
The Missouri attorney general’s office has filed a lawsuit against 19 pharmacy benefit managers and drug manufacturers, alleging they conspired to inflate insulin prices and deceive consumers. The lawsuit claims the defendants engaged in deceptive and unfair practices that caused…
UnitedHealth Group’s Optum Rx is monitoring three notable drug candidates that might be approved in the next few months, according to its winter 2026 report published Jan. 2. Two of the medications Optum Rx is tracking are also on GoodRx’s…
The FDA delayed reviews of two drugs selected for its National Priority Voucher Program due to safety and efficacy concerns, according to internal documents reported in an exclusive Jan. 15 report by Reuters. Sanofi’s bid to expand Tzield for late-stage…
The Board of Pharmacy Specialties, a certification agency, has recognized Essentia Health Fargo (N.D.) for supporting professional growth in pharmacy specialties. Through intentional investment, Essentia Health Fargo has increased its number of certified specialty pharmacists from three in 2019 to…
Strive Compounding Pharmacy filed a federal antitrust lawsuit Jan. 14 against Eli Lilly and Novo Nordisk, alleging the two drugmakers used their market power to restrict access to compounded GLP-1 medications and suppress competition. The lawsuit, filed in the U.S.…
Delaware Attorney General Kathy Jennings filed a lawsuit Jan. 14 against three drugmakers and three pharmacy benefit managers, alleging they conspired to inflate insulin prices by up to 1,000% over 15 years. The complaint, filed in the state’s Court of…
At many health systems, infusion services operate across multiple sites with varying workflows and approval processes. At Cone Health, based in Greensboro, N.C., pharmacy leaders have spent the past year aligning those services — particularly outside of oncology — as…